Brainstorm Cell Therapeutics, Inc. (BCLI) Is Worth Looking Despite A Loss Of -626.09% From High
Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) price on Friday, May 10, fall -2.36% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.46. A look at the stock’s price movement, the close in the last trading session was $0.47.